| | | | | | | Sponsored | | Optimize your lab with Bio-Rad’s quality control solutions. Join our series tailored to lab directors, featuring exclusive tools and insights to ensure compliance and inspire your team. |
|
|
|
| |
| | |
|
|
| | | | | | A collaboration between Yale School of Medicine and the Frazer Institute at the University of Queensland has led to the development of a non-small cell lung cancer (NSCLC) personalized treatment map, according to an announcement. |
|
|
| | In this online exclusive interview, Olga Colgan, PhD discusses how artificial intelligence (AI) is shaping the future of digital pathology in clinical laboratories. |
|
|
|
| |
| | |
|
|
| | | | Sponsored | | The acquisition of Orchard Software by Clinisys marks a significant milestone in the laboratory informatics industry, promising accelerated innovation, broader solution offerings, and enhanced support for laboratories worldwide. The combined expertise and resources will help laboratories improve efficiency, compliance, and patient outcomes in an increasingly complex healthcare environment. |
|
|
|
| |
| | |
|
|
| | | | | | Veracyte, Inc. announced that new data from the prospective, randomized integral biomarker BALANCE trial found that the PAM50 molecular signature predicts which patients with recurrent prostate cancer benefit from hormone therapy with apalutamide in addition to salvage radiation therapy. |
|
|
|
| |
| | |
|
|
| | | | | | Your team’s innovation, dedication, and excellence deserve recognition. Submit your nomination for MLO’s Lab of the Year—and celebrate the incredible work happening in your lab every day. |
|
|
|
| |
| | |
|
|
| | | | Sponsored | | Verify precise and reliable results for your Radiometer ABL90 values now available with RNA Medical’s CVC 223 Calibration Verification Controls. Specifically designed to confirm calibration, linearity, and reportable range across 5 critical levels, CVC 223 helps maintain optimal performance of your CO-Oximetry results. Trust the accuracy of your measurements for crucial analytes such as tHb, O2Hb, COHb, and MetHb. |
|
|
|
| |
| | |
|
|
| | | | | | Resitu Medical, has received FDA 510(k) clearance to market its RESL09 device for the process of obtaining breast tissue for the diagnostic analysis of imaged abnormalities. |
|
|
|
| |
| | |
|
|
| | |
|
| | |
|
